Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells
- 6 March 2024
- journal article
- research article
- Published by Springer Nature in Nature Cancer
- Vol. 5 (6) , 895-915
Abstract
Gemcitabine is a potent inhibitor of DNA replication and is a mainstay therapeutic for diverse cancers, particularly pancreatic ductal adenocarcinoma (PDAC). However, most tumors remain refractory to gemcitabine therapies. Here, to define the cancer cell response to gemcitabine, we performed genome-scale CRISPR–Cas9 chemical–genetic screens in PDAC cells and found selective loss of cell fitness upon disruption of the cytidine deaminases APOBEC3C and APOBEC3D. Following gemcitabine treatment, APOBEC3C and APOBEC3D promote DNA replication stress resistance and cell survival by deaminating cytidines in the nuclear genome to ensure DNA replication fork restart and repair in PDAC cells. We provide evidence that the chemical–genetic interaction between APOBEC3C or APOBEC3D and gemcitabine is absent in nontransformed cells but is recapitulated across different PDAC cell lines, in PDAC organoids and in PDAC xenografts. Thus, we uncover roles for APOBEC3C and APOBEC3D in DNA replication stress resistance and offer plausible targets for improving gemcitabine-based therapies for PDAC.Keywords
Funding Information
- Gouvernement du Canada | Canadian Institutes of Health Research (FDN-159913, PJT-463531, FRN 166094)
- Canada Research Chairs
- Canadian Cancer Society Research Institute (Innovate grant 706293)
- Ontario Institute for Cancer Research (P.CTIP.1005)
- Ontario Ministry of Colleges and Universities
- GlaxoSmithKline Chair in Genetics and Genome Biology at the Hospital for Sick Children
- Princess Margaret Cancer Foundation
- Terry Fox Research Institute
- Canadian Friends of the Hebrew University
- Lustgarten Foundation
- U.S. Department of Health & Human Services | National Institutes of Health (5P30CA45508, U01CA210240, R01CA229699, U01CA224013, 1R01CA188134, and 1R01CA190092)
- Simons Foundation (552716)
- Cold Spring Harbor Laboratory Association Cold Spring Harbor Laboratory and Northwell Health Affiliation Northwell Health Tissue Donation Program
- Canada Foundation for Innovation (grant 37660)
- Hungarian Academy of Sciences | Magyar Tudományos Akadémia Számítástechnikai és Automatizálási Kutatóintézet
- National Research, Development and Innovation Fund of Hungary
This publication has 80 references indexed in Scilit:
- Dual proteome-scale networks reveal cell-specific remodeling of the human interactomeCell, 2021
- The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactionsProtein Science, 2020
- A Genetic Map of the Response to DNA Damage in Human CellsCell, 2020
- Alternative splicing of APOBEC3D generates functional diversity and its role as a DNA mutatorInternational Journal of Hematology, 2020
- Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in MetastasesCancer Cell, 2019
- HMCES Maintains Genome Integrity by Shielding Abasic Sites in Single-Strand DNACell, 2019
- Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome AtlasCell Reports, 2018
- A novel method for quantification of gemcitabine and its metabolites 2′,2′-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC–MS/MS: comparison with 19F NMR spectroscopyCancer Chemotherapy and Pharmacology, 2011
- High‐Throughput Real‐Time Quantitative Reverse Transcription PCRCurrent Protocols in Molecular Biology, 2006
- [42] Preparation and enzymatic hydrolysis of DNA and RNA for mass spectrometry1990